Privia Health Files Routine 8-K for Regulation FD Disclosure

Ticker: PRVA · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1759655

Privia Health Group, Inc. 8-K Filing Summary
FieldDetail
CompanyPrivia Health Group, Inc. (PRVA)
Form Type8-K
Filed DateJan 8, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulation-fd, compliance, routine-filing

TL;DR

**Privia Health filed a routine 8-K, no major news here.**

AI Summary

Privia Health Group, Inc. (PRVA) filed an 8-K on January 8, 2024, to disclose information under Regulation FD and to include financial statements and exhibits. This filing is a routine disclosure, indicating no major new events but rather a formal update on previously shared information or minor operational details. For investors, this means there are no immediate red flags or significant positive catalysts revealed in this specific filing, suggesting a neutral impact on the stock unless the undisclosed Regulation FD information contains material news.

Why It Matters

This filing is a standard procedural update, indicating that Privia Health Group is complying with SEC regulations by formally disclosing information that may have been shared previously or is not considered a major event.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure for Regulation FD and exhibits, which typically does not introduce new risks.

Analyst Insight

Given this is a routine compliance filing without specific material news, a smart investor would monitor subsequent filings or news releases for the actual content of the Regulation FD disclosure or any significant financial updates, as this 8-K itself provides no actionable information.

Key Numbers

  • 001-40365 — Commission File No. (SEC identification number for Privia Health Group, Inc.)
  • 81-3599420 — I.R.S. Employer Identification No. (IRS identification number for Privia Health Group, Inc.)
  • 571-366-8850 — Registrant's telephone number (contact number for Privia Health Group, Inc.)

Key Players & Entities

  • Privia Health Group, Inc. (company) — the registrant filing the 8-K
  • PRVA (company) — the trading symbol for Privia Health Group, Inc.
  • The Nasdaq Global Select Market (company) — the exchange where Privia Health Group's common stock is registered
  • January 8, 2024 (date) — the date of the earliest event reported and filing date
  • $0.01 (dollar_amount) — par value per share of common stock

FAQ

What is the purpose of Privia Health Group, Inc.'s 8-K filing on January 8, 2024?

The 8-K filing by Privia Health Group, Inc. on January 8, 2024, is for Regulation FD Disclosure and to include Financial Statements and Exhibits, as stated in the 'ITEM INFORMATION' section of the filing.

What is the trading symbol and the exchange where Privia Health Group, Inc.'s common stock is registered?

Privia Health Group, Inc.'s common stock trades under the symbol PRVA and is registered on The Nasdaq Global Select Market, as indicated under 'Securities registered pursuant to Section 12(b) of the Act'.

What is the state of incorporation for Privia Health Group, Inc.?

Privia Health Group, Inc. is incorporated in Delaware, as specified under 'State or other jurisdiction of incorporation or organization'.

What is the business address of Privia Health Group, Inc.?

The business address of Privia Health Group, Inc. is 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203, according to the 'BUSINESS ADDRESS' section.

Did Privia Health Group, Inc. indicate if it is an emerging growth company in this filing?

The filing includes a checkbox '☐' next to the statement 'Indicate by check mark whether the registrant is an emerging growth company...', but it is not checked, implying they are not indicating themselves as an emerging growth company in this specific filing.

Filing Stats: 608 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-01-08 08:01:31

Key Financial Figures

  • $0.01 — ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. We are furnishing this Current Report on Form 8-K to furnish materials that will be provided at meetings with institutional investors or analysts. The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com . This information may be amended or updated at any time and from time to time through another Current Report on Form 8-K, a later company filing, or other means. The information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD. We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibit: Exhibit No. Description 99.1 Privia Health Group, Inc. Investor Presentation Slides - January 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: January 8, 2024 By: /s/ David Mountcastle Name: David Mountcastle Title: Executive Vice President, Chief Financial Officer and Authorized Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.